doomed
3 weeks ago
Klein’s growing moldy bunk days are over…
Canopy Growth Announces CEO Succession Plan
Doomed
August 16, 2024
ImageCanopy Growth Announces CEO Succession Plan
Canopy Growth Announces CEO David Klein’s Retirement After Transformative Tenure, Search for New Leadership Begins as Company Focuses on Continued Growth and Profitability.
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced today that CEO David Klein will be retiring at the end of the company’s fiscal year on March 31, 2025. Until a successor is named, Klein will continue in his role, focusing on advancing Canopy Growth’s strategic objectives, including profitability, and ensuring a smooth transition for the incoming CEO. The Board has initiated a comprehensive search process to identify a candidate with the skills and experience needed to lead the company into its next phase of growth.
Klein, who joined Canopy Growth in January 2020, has been pivotal in transforming the company into a leaner, more focused organization🤣.
Under his leadership, Canopy Growth adopted an asset-light model in Canada and international markets, including Germany, and launched Canopy USA, giving shareholders unique exposure to the U.S. cannabis market ahead of federal legalization. His tenure is marked by the recent first-quarter results for fiscal year 2025, which showed a 67% increase in gross profit year-over-year and a consolidated gross margin of 35%, reflecting the company’s improved financial position.
Klein expressed his gratitude to the Canopy Growth team and shareholders, emphasizing his commitment to driving the company toward profitability in his remaining months. He stated that his experience at Canopy Growth has reinforced his belief in the power of cannabis to improve lives and that he is confident in the company’s future.
David Lazzarato, Chairman of the Board, praised Klein’s leadership, noting his instrumental role in the company’s transformation and the establishment of Canopy USA. The Board remains committed to appointing a new CEO who will continue to drive Crappy Growth’s ambitious vision, ensuring that the company remains a leader in the global cannabis market.
This leadership transition comes at a crucial time for Canopy Growth as it continues to strengthen its position in the competitive cannabis industry.😂
borysek
2 months ago
Canopy Growth Corporation Common Shares is estimated to report earnings on 08/14/2024. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.32. The reported EPS for the same quarter last year was $-0.4.
===========================================================================
so we will see another big loss of millions of $ ...
doomed
2 months ago
Home / Cultivation
Judge keeps Alabama medical marijuana licensing on hold
By Doomed
July 8, 2024
An Alabama judge has extended a temporary restraining order on the issuance of medical marijuana business licenses in yet another delay to the market’s launch.
Montgomery County Circuit Judge James Anderson, according to the Alabama Reflector, also instructed the state’s Medical Cannabis Commission to begin investigative hearings requested by companies denied licenses in the previous round.
The restraining order was pushed by Alabama Always, an MMJ company seeking one of the state’s vertically integrated licenses.
Last December, Alabama regulators issued five integrated licenses to MMJ companies, including:
Flowerwood Medical Cannabis.
Specialty Medical Products of Alabama.
Sustainable Alabama.
Trulieve AL.
Wagon Trail Med-Serv.
The application and selection process for those integrated licenses sparked lawsuits after the state’s first two attempts to issue them.
A judge blocked a third round of MMJ licensing in January after noting “a serious question” as to whether it “is also invalid.”
Meanwhile, more than three years have passed since the governor signed into law the Alabama Compassionate Act, which allowed MMJ products for patients suffering from a host of chronic health issues.